StockData
Enliven Therapeutics, Inc. logo

Enliven Therapeutics, Inc. (ELVN) dividend history

ELVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30
$44.89−1.96 (-4.18%)

Close on Nov 18, 2026Market cap $3.29BP/E –Yield –

Dividends

Enliven Therapeutics has not reported a dividend

No dividend per share appears in Enliven Therapeutics's annual filings since fiscal 2018.

See a number that looks wrong?